NPI Lens

Mark T. Hodgman, M.D.

NPI 1093740193ActiveIndividual· Internal Medicine, Cardiovascular Disease· Milton, MA

Internal Medicine, Cardiovascular Disease (M.D.) in Milton, Massachusetts, licensed in MA, with an NPI issued in July 2006. Part D covered 26 prescriptions written in 2024, 92% of them generic. Bridgebio Pharma, Inc. reported $26.03 in payments in 2025, mostly food and beverage.

Overview

NPI1093740193
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 11, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000X43405MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (MA)

Part D prescriptions in 2024

Prescriptions (claims)26 · 38 30-day fills
Total drug cost$3,575
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$26.03 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Bridgebio Pharma, Inc.$26.031

What the 2025 payments were for

  • Food and Beverage$26.03 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Milton

All Internal Medicine, Cardiovascular Disease providers in Massachusetts →